MedTrace Logo

Tab Block and Patient Controlled Analgesia in CS

NCT04405336 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2021-05-25

No results posted yet for this study

Summary

cesarean section rate become increasing nowadays

Conditions

  • Analgesia

Interventions

DRUG

tab block

injection of tab block to women who are doing cs

DRUG

PCA

giving women PCA

DRUG

women who will not receive tab block or PCA

no tab block or PCA will be given

Sponsors & Collaborators

  • Aljazeera Hospital

    lead OTHER

Principal Investigators

  • Mahmoud Alalfy, PhD · Algezeera hospitaland National Research Centre ,Egypt

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-28
Primary Completion
2021-03-15
Completion
2021-04-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04405336 on ClinicalTrials.gov